Related references
Note: Only part of the references are listed.Enhanced alpha-Synuclein Expression in Human Neurodegenerative Diseases: Pathogenetic and Therapeutic Implications
Alison L. McCormack et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2009)
Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease
Samareh Azeredo da Silveira et al.
HUMAN MOLECULAR GENETICS (2009)
Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System
Kelly J. Inglis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
14-3-3ζ Contributes to Tyrosine Hydroxylase Activity in MN9D Cells LOCALIZATION OF DOPAMINE REGULATORY PROTEINS TO MITOCHONDRIA
Jian Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Differential gene expression involved in oxidative stress response caused by triethylene glycol dimethacrylate
Helmut Schweikl et al.
BIOMATERIALS (2008)
Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease
Jose Bras et al.
FEBS JOURNAL (2008)
Pathologic modifications of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) -: Treated squirrel monkeys
Alison L. McCormack et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Specificity and regulation of casein kinase-mediated phosphorylation of α-synuclein
Elisa A. Waxman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Silencing α-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells
Dongmei Liu et al.
NEUROCHEMICAL RESEARCH (2008)
α-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity:: Lessons from viral transduction of knockout mice
Tshianda N. M. Alerte et al.
NEUROSCIENCE LETTERS (2008)
The phosphorylation state of Ser-129 in human α-synuclein determines neurodegeneration in a rat model of Parkinson disease
Oleg S. Gorbatyuk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human α-synuclein:: Implication for α-synucleinopathies
Aasami Ishii et al.
FEBS LETTERS (2007)
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration
W. Michael Caudle et al.
JOURNAL OF NEUROSCIENCE (2007)
Protein kinase Cδ negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons
Danhui Zhang et al.
JOURNAL OF NEUROSCIENCE (2007)
Differential expression of the B′ β regulatory subunit of protein phosphatase 2A modulates tyrosine hydroxylase phosphorylation and catecholamine synthesis
Amit Saraf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease
Nicolaas I. Bohnen et al.
JOURNAL OF NEUROLOGY (2007)
Sustained phosphorylation of tyrosine hydroxylase at serine 40: a novel mechanism for maintenance of catecholamine synthesis
Larisa Bobrovskaya et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
Yaping Chu et al.
NEUROBIOLOGY OF DISEASE (2007)
α-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis
Kristin E. Larsen et al.
JOURNAL OF NEUROSCIENCE (2006)
Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells
Roya Tehranian et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Chaperone and anti-chaperone: Two-faced synuclein as stimulator of synaptic evolution
Masayo Fujita et al.
NEUROPATHOLOGY (2006)
Chaperone-like activities of α-synuclein:: α-Synuclein assists enzyme activities of esterases
Misun Ahn et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease
Demetrius M. Maraganore et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation
Meiguo Xin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes
DG Adams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
α-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates
MG Purisai et al.
NEUROBIOLOGY OF DISEASE (2005)
Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt
MJ Van Kanegan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells
XMM Peng et al.
JOURNAL OF CELL SCIENCE (2005)
α-Synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells
WW Smith et al.
JOURNAL OF NEUROSCIENCE (2005)
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
L Chen et al.
NATURE NEUROSCIENCE (2005)
Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease
GD Mellick et al.
NEUROSCIENCE LETTERS (2005)
Mutation of regulatory serines of rat tyrosine hydroxylase to glutamate: effects on enzyme stability and activity
M Royo et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
Effects of mutations in tyrosine hydroxylase associated with progressive dystonia on the activity and stability of the protein
M Royo et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Aging of the nigrostriatal system in the squirrel monkey
AL McCormack et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Casein kinase II-mediated phosphorylation regulates α-synuclein/synphilin-1 interaction and inclusion body formation
G Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Phosphorylated α-synuclein in normal mouse brain
Y Hirai et al.
FEBS LETTERS (2004)
Phosphorylation of Ser19 increases both Ser40 phosphorylation and enzyme activity of tyrosine hydroxylase in intact cells
L Bobrovskaya et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Tyrosine hydroxylase phosphorylation: regulation and consequences
PR Dunkley et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Could a loss of α-synuclein function put dopaminergic neurons at risk?
RG Perez et al.
JOURNAL OF NEUROCHEMISTRY (2004)
α-synuclein promoter confers susceptibility to Parkinson's disease
P Pals et al.
ANNALS OF NEUROLOGY (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Role of protein phosphatase 2C from bovine adrenal chromaffin cells in the dephosphorylation of phospho-serine 40 tyrosine hydroxylase
LRM Bevilaqua et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Accumulation of phosphorylated α-synuclein in aging human brain
Y Saito et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
α-Synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells:: role in the pathogenesis of Parkinson's disease
M Hashimoto et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Co-ordinate transcriptional regulation of dopamine synthesis genes by α-synuclein in human neuroblastoma cell lines
MJ Baptista et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Attenuation of dopamine transporter activity by α-synuclein
C Wersinger et al.
NEUROSCIENCE LETTERS (2003)
Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation
J Haendeler et al.
FEBS LETTERS (2003)
Structural and functional implications of C-terminal regions of α-synuclein
TD Kim et al.
BIOCHEMISTRY (2002)
Regulation of tyrosine hydroxylase by stress-activated protein kinases
K Toska et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Impaired dopamine storage resulting from α-synuclein mutations may contribute to the pathogenesis of Parkinson's disease
J Lotharius et al.
HUMAN MOLECULAR GENETICS (2002)
Microscopic analysis of polymerization dynamics with individual actin filaments
I Fujiwara et al.
NATURE CELL BIOLOGY (2002)
The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases
B Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Comparison analysis of distributions of tyrosine hydroxylase, calmodulin and calcium/calmodulin-dependent protein kinase II in a triple stained slice of rat brain
D Sutoo et al.
BRAIN RESEARCH (2002)
A-synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells
BH Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice -: Paraquat and α-synuclein
AB Manning-Bog et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tyrosine hydroxylase dephosphorylation by protein phosphatase 2A in bovine adrenal chromaffin cells
RB Leal et al.
NEUROCHEMICAL RESEARCH (2002)
Depolarization-stimulated catecholamine biosynthesis:: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ
MF Salvatore et al.
JOURNAL OF NEUROCHEMISTRY (2001)
α-synuclein gene haplotypes are associated with Parkinson's disease
M Farrer et al.
HUMAN MOLECULAR GENETICS (2001)
Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter
Y Matsuoka et al.
NEUROBIOLOGY OF DISEASE (2001)
Interaction of phosphorylated tyrosine hydroxylase with 14-3-3 proteins: evidence for a phosphoserine 40-dependent association
R Kleppe et al.
JOURNAL OF NEUROCHEMISTRY (2001)
α-synuclein forms a complex with transcription factor Elk-1
A Iwata et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Postnatal expression of α-synuclein protein in the rodent substantia nigra and striatum
MW Jakowec et al.
DEVELOPMENTAL NEUROSCIENCE (2001)
Structural changes in α-synuclein affect its chaperone-like activity in vitro
TD Kim et al.
PROTEIN SCIENCE (2000)
Synucleins are a novel class of substrates for G protein-coupled receptor kinases
AN Pronin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Stoichiometry of tyrosine hydroxylase phosphorylation in the nigrostriatal and mesolimbic systems in vivo: Effects of acute haloperidol and related compounds
MF Salvatore et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Chaperone-like activity of synucleins
JM Souza et al.
FEBS LETTERS (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
α-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP
M Vila et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Olfaction in Parkinson's disease: methods of assessment and clinical relevance
P Liberini et al.
JOURNAL OF NEUROLOGY (2000)
Constitutive phosphorylation of the Parkinson's disease associated α-synuclein
M Okochi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
Share Paper
